CureVac is back in the Covid-19 vaccine game, this time with ‘lessons learned’

CureVac NV, a German biopharmaceutical company with U.S. headquarters in Boston, is back in the Covid-19 vaccine game — about a year after it abandoned its first attempt. The CEO detailed the company's approach this time.

Signature KC Cocktails: Swordfish Tom’s Thai Basil (Video)

Breaking: Truist names new top Central Florida executive

Apartments next to Lakewood’s Belmar Park face backlash, but city leaders take no action

How does the Rays’ $600 million in public funding stack up to other new stadiums?

Blue Run Spirits inks financing deal with Truist

Julie Powell, who changed the way we write about cooking, dies

Modular home builder Veev is cutting 30% of its staff 8 months after scoring $400M in funding

David Ottati guides AdventHealth’s growth in Tampa Bay

CureVac is back in the Covid-19 vaccine game, this time with ‘lessons learned’

Previous Art Oberto, showman behind beef jerky producer, dies at 95

Next Houston-based real estate firm Arrowstar sees growth from focusing on value-add apartments

firststargroup

Kotek touts $500M Oregon housing plan at Leadership Summit

Retirement plans see boost as states mandate IRAs and tax credits lower costs

Norton Healthcare data breach affected more than 2 million people

Houston-based cell therapy company FibroBiologics files to go public

Suggested Posts

Lots of new homes coming to tiny town 45 minutes from Raleigh

Detroit coworking company expands to downtown St. Pete

Trust administration trends: Special needs trusts

Here are the Los Angeles leases WeWork plans to reject as part of its bankruptcy

Beer garden, museum on historic Katy rice dryer property slated to open this year

Top 10 home sales in the Triad for the week of Oct. 28

MENU

FirstStar Group

More Stories

Chick-fil-A again boosts scholarships for restaurant team members — to $15.3M